ANI PHARMACEUTICALS INC. - COMMON STOCK
62.45
12-十一月-24 13:30:52
15 分钟延时
股票
+0.71
+1.15%
今日范围
61.63 - 62.91
ISIN
N/A
来源
NASDAQ
-
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
08 11月 2024 05:50:28 条件 Nasdaq GlobeNewswire
-
04 11月 2024 15:30:00 条件 Nasdaq GlobeNewswire
-
30 10月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
25 10月 2024 05:50:54 条件 Nasdaq GlobeNewswire
-
24 10月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
26 9月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
16 9月 2024 07:53:27 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
16 9月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
13 9月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
11 9月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
10 9月 2024 13:09:55 条件 Nasdaq GlobeNewswire
-
13 8月 2024 15:05:27 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering
07 8月 2024 20:44:18 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
07 8月 2024 06:00:55 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance
06 8月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
31 7月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder
15 7月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP
02 7月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
25 6月 2024 06:00:02 条件 Nasdaq GlobeNewswire
-
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
24 6月 2024 05:50:44 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >